18 June 2013
Keywords: daiichi, fy, net, income, forecast, soar, tokyo
Article | 01 March 2004
Tokyo, Japan-headquartered Daiichi Pharmaceuticals has reported first nine months cumulative sales of 254.2 billion yen ($2.4 billion), accounting for 79% of its full-year ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.